| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2018 | Jun 27, 2018 | Kezar Life Sciences, Inc. | 10% Owner | Buy | 100.0 | +250,000 | 18.90% | ✗ | $3.8M |
| May 29, 2018 | May 31, 2018 | Kiniksa Pharmaceuticals International, plc | 10% Owner | Buy | 95.0 | +69,444 | 8.36% | ✗ | $1.2M |